Earl R Lewis - Net Worth and Insider Trading
Earl R Lewis Net Worth
The estimated net worth of Earl R Lewis is at least $46 Million dollars as of 2024-04-20. Earl R Lewis is the Director of FLIR Systems Inc and owns about 729,003 shares of FLIR Systems Inc (FLIR) stock worth over $42 Million. Earl R Lewis is the Director of NxStage Medical Inc and owns about 88,145 shares of NxStage Medical Inc (NXTM) stock worth over $3 Million. Earl R Lewis is also the Director of Harvard Bioscience Inc and owns about 467,350 shares of Harvard Bioscience Inc (HBIO) stock worth over $2 Million. Besides these, Earl R Lewis also holds Tecogen Inc (TGEN) , American DG Energy Inc (ADGE) . Details can be seen in Earl R Lewis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Earl R Lewis has not made any transactions after 2024-01-24 and currently still holds the listed stock(s).
Transaction Summary of Earl R Lewis
Earl R Lewis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Earl R Lewis owns 7 companies in total, including Tecogen Inc (TGEN) , FLIR Systems Inc (FLIR) , and NxStage Medical Inc (NXTM) among others .
Click here to see the complete history of Earl R Lewis’s form 4 insider trades.
Insider Ownership Summary of Earl R Lewis
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TGEN | Tecogen Inc | 2024-01-24 | director |
FLIR | FLIR Systems Inc | 2020-11-04 | director |
NXTM | NxStage Medical Inc | 2019-02-21 | director |
HBIO | Harvard Bioscience Inc | 2017-05-25 | director |
ADGE | American DG Energy Inc | 2010-09-02 | director |
TLGTQ | Teligent Inc | 2003-03-31 | director |
GTHP | Guided Therapeutics Inc | 2003-05-22 | director |
Earl R Lewis Latest Holdings Summary
Earl R Lewis currently owns a total of 5 stocks. Among these stocks, Earl R Lewis owns 729,003 shares of FLIR Systems Inc (FLIR) as of November 4, 2020, with a value of $42 Million and a weighting of 89.76%. Earl R Lewis owns 88,145 shares of NxStage Medical Inc (NXTM) as of February 12, 2016, with a value of $3 Million and a weighting of 5.7%. Earl R Lewis also owns 467,350 shares of Harvard Bioscience Inc (HBIO) as of May 25, 2017, with a value of $2 Million and a weighting of 3.71%. The other 2 stocks Tecogen Inc (TGEN) , American DG Energy Inc (ADGE) have a combined weighting of 0.83% among all his current holdings.
Latest Holdings of Earl R Lewis
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FLIR | FLIR Systems Inc | 2020-11-04 | 729,003 | 57.17 | 41,677,102 |
NXTM | NxStage Medical Inc | 2016-02-12 | 88,145 | 30.00 | 2,644,350 |
HBIO | Harvard Bioscience Inc | 2017-05-25 | 467,350 | 3.69 | 1,724,522 |
TGEN | Tecogen Inc | 2024-01-24 | 560,835 | 0.63 | 353,287 |
ADGE | American DG Energy Inc | 2010-09-02 | 105,000 | 0.32 | 33,285 |
Holding Weightings of Earl R Lewis
Earl R Lewis Form 4 Trading Tracker
According to the SEC Form 4 filings, Earl R Lewis has made a total of 4 transactions in FLIR Systems Inc (FLIR) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in FLIR Systems Inc is the sale of 30,000 shares on November 4, 2020, which brought Earl R Lewis around $1 Million.
According to the SEC Form 4 filings, Earl R Lewis has made a total of 0 transactions in NxStage Medical Inc (NXTM) over the past 5 years. The most-recent trade in NxStage Medical Inc is the acquisition of 21,000 shares on February 12, 2016, which cost Earl R Lewis around $307,230.
According to the SEC Form 4 filings, Earl R Lewis has made a total of 0 transactions in Harvard Bioscience Inc (HBIO) over the past 5 years. The most-recent trade in Harvard Bioscience Inc is the acquisition of 12,238 shares on May 25, 2017, which cost Earl R Lewis around $28,759.
More details on Earl R Lewis's insider transactions can be found in the Insider Trading History of Earl R Lewis table.Insider Trading History of Earl R Lewis
- 1
Earl R Lewis Trading Performance
GuruFocus tracks the stock performance after each of Earl R Lewis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Earl R Lewis is 1.35%. GuruFocus also compares Earl R Lewis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Earl R Lewis within 3 months outperforms 9 times out of 24 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Earl R Lewis's insider trading performs compared to the benchmark.
Performance of Earl R Lewis
Average Return
24.1%
Outperforming Transactions
44%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 3.1 | 1.35 | 10.91 | 24.1 | 14.74 | 10.75 |
Relative Return to S&P 500(%) | 0.97 | -2.66 | 0.57 | 8.66 | 5.26 | 3.01 |
Earl R Lewis Ownership Network
Ownership Network List of Earl R Lewis
Ownership Network Relation of Earl R Lewis
Earl R Lewis Owned Company Details
What does Tecogen Inc do?
Who are the key executives at Tecogen Inc?
Earl R Lewis is the director of Tecogen Inc. Other key executives at Tecogen Inc include director & 10 percent owner & Chief Executive Officer John Hatsopoulos , director & Chief Financial Officer Abinand Rangesh , and 10 percent owner & other: Trustee Pacheco Ann Marie Brown .
Tecogen Inc (TGEN) Insider Trades Summary
Over the past 18 months, Earl R Lewis made 11 insider transaction in Tecogen Inc (TGEN) with a net purchase of 132,652. Other recent insider transactions involving Tecogen Inc (TGEN) include a net purchase of 559,522 shares made by John Hatsopoulos , a net purchase of 4,301 shares made by Abinand Rangesh , and a net purchase of 5,000 shares made by Susan B Hirsch .
In summary, during the past 3 months, insiders sold 0 shares of Tecogen Inc (TGEN) in total and bought 45,152 shares, with a net purchase of 45,152 shares. During the past 18 months, 0 shares of Tecogen Inc (TGEN) were sold and 701,475 shares were bought by its insiders, resulting in a net purchase of 701,475 shares.
Tecogen Inc (TGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tecogen Inc Insider Transactions
Earl R Lewis Mailing Address
Above is the net worth, insider trading, and ownership report for Earl R Lewis. You might contact Earl R Lewis via mailing address: C/o Nxstage Medical Inc. (nxtm), 439 South Union Street, 5th Floor, Lawrence Ma 01843.